chevron_leftBack
As of 14 June 2026, CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. has a market cap of $1.91B USD, ranking #7259 globally and #1803 in China.
It ranks #584 in the Healthcare sector, and #230 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.91BUSD
12.97B CNY
Enterprise Value
$1.65BUSD
11.17B CNY
Revenue (TTM)
$56.9MUSD
385.54M CNY
EBITDA (TTM)
$1.44MUSD
9.78M CNY
Net Income (TTM)
-$9.64MUSD
-65.32M CNY
EBITDA Margin
2.5%
Profit Margin
-17%
PS Ratio
33.6
PB Ratio
6.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dong Yang
open_in_new
Employees
547
Founded
1998
Website
jfzhiyao.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.4% | 4.4% | -5.1% | -1.3% | -8.7% | 36% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
000908
湖南景峰医药股份有限公司 Class A
ISIN: CNE000000Y11
Shares Out.:
Shares Outstanding:
1.76B1
Shares Float:
1.668B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
7.12 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.
CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. manufactures and sells chemical drugs and biological agents in China. The company’s principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the fields of cardiovascular disease, orthopedic pain disease, tumor disease, women and children. The company was formerly known as Hunan Jingfeng Pharmaceutical Co.,Ltd. and changed its name to CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. in April 2026. The company was founded in 1998 and is headquartered in Changde, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
2K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
1K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
882%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
763%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
736%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
40K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
28K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
19K%
|
97.4
|
|
SIX: RO
|
$321.52B
17K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
15K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
14K%
218.9B CHF
|
20.5
|
chevron_leftBack